Solving it Together
X
An Investment Partnership to End the Opioid Epidemic
Solving it Together
X
An Investment Partnership to End the Opioid Epidemic
Watch the Video Now...
Visionary leaders MJ Gottlieb, Founder and CEO of Loosid App, and Jim Iversen, Co-Founder and CEO of Sen-Jam Pharmaceutical, are revolutionizing addiction recovery. These innovative startups are at the forefront of combating the opioid epidemic, offering investors a unique opportunity to engage with their missions and potential. Click below to learn how your investment can enhance both Loosid's digital platform, which supports recovery and sober living, and Sen-Jam's development of cutting-edge pharmaceutical solutions to reduce opioid dependency.
Discover the synergy between these approaches, their market potential, and the profound impact they could have on millions of lives. Don’t miss the chance to connect with two companies that are transforming the health landscape and working to solve one of the most pressing crises of our time.
Watch the Video Now...
Visionary leaders MJ Gottlieb, Founder and CEO of Loosid App, and Jim Iversen, Co-Founder and CEO of Sen-Jam Pharmaceutical, are revolutionizing addiction recovery. These innovative startups are at the forefront of combating the opioid epidemic, offering investors a unique opportunity to engage with their missions and potential. Click below to learn how your investment can enhance both Loosid's digital platform, which supports recovery and sober living, and Sen-Jam's development of cutting-edge pharmaceutical solutions to reduce opioid dependency.
Discover the synergy between these approaches, their market potential, and the profound impact they could have on millions of lives. Don’t miss the chance to connect with two companies that are transforming the health landscape and working to solve one of the most pressing crises of our time.
Here’s the Story Behind Each Company and What Makes Them Game-Changers
Sen-Jam Pharmacutical
Loosid Sober Community
Here’s the Story Behind Each Company and What Makes Them Game-Changers
Sen-Jam Pharmaceutical is focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVID-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover.
WANT TO LEARN MORE ABOUT SEN-JAM AND LOOSID? SUBSCRIBE BELOW FOR MORE INFORMATION.
I Consent to Receive SMS Notifications, Alerts & Occasional Marketing Communication from Company. Message frequency varies. Message & data rates may apply. You can reply STOP to unsubscribe at any time.
We believe this is a phenomenal chance to make history as we, together, change the course of addiction for good.Loosid and Sen-Jam are determined to turn the tides on the Opioid Crisis.
WANT TO LEARN MORE ABOUT SEN-JAM AND LOOSID? SUBSCRIBE BELOW FOR MORE INFORMATION
I Consent to Receive SMS Notifications, Alerts & Occasional Marketing Communication from Company. Message frequency varies. Message & data rates may apply. You can reply STOP to unsubscribe at any time.
We believe this is a phenomenal chance to make history as we, together, change the course of addiction for good.Loosid and Sen-Jam are determined to turn the tides on the Opioid Crisis.
Sen-Jam and Loosid believe that, together, we can help people overcome opioid addiction through Sen-Jam's non-opioid medication that reduces the severity and duration of withdrawal, as well as cravings, while Loosid provides the social community and human support needed for these individuals to find a path to meaningful recovery.
The epidemic is too complex for a single solution, but together, we can make a real impact. The world needs both.
Sen-Jam and Loosid believe that, together, we can help people overcome opioid addiction through Sen-Jam's non-opioid medication that reduces the severity and duration of withdrawal, as well as cravings, while Loosid provides the social community and human support needed for these individuals to find a path to meaningful recovery.
The epidemic is too complex for a single solution, but together, we can make a real impact. The world needs both.
Our Team
Sen-Jam Pharmaceutical
Jim Iversen
Co-Founder, CEO
Serial entrepreneur and innovative disruptor. 5 exits at $80M. Scaled companies from 0-160 employees and to $50M revenue at W&H Systems, Mincron, and AL Systems. Seasoned CEO and global humanitarian. BS Mechanical Engineering.
Jackie Iversen
Co-Founder, Head of Clinical Development
Pharmacist & clinical research expert in pharmacokinetics & pain management. Leading clinical pain educator. Cited in 20+ scientific publications including Pharmacy Times. Memorial Sloan Kettering Fellow. BS Pharmacy, MS Pharmacy, St. John’s University.
Thomas Dahl, PhD
Head of Product Development and Regulatory Affairs
Pharmaceutical clinical development and regulatory expert. Former biotech or
pharmaceutical executive at Synta, ViuRX, Arietis, Greatbrook Biotech. Biochemistry & Biology PhD, John Hopkins University.
Loosid Sober Community
MJ Gottlieb
Co-Founder, CEO
MJ Gottlieb, a serial entrepreneur and recovery advocate, has led multiple brands and agencies over 29 years. Featured in top publications and author of How To Ruin A Business Without Really Trying, he has been sober since 2012 and hosts Loosid’s Recovery Voices.
Zhanna Basina
Co-Founder, Senior Advisor
Zhanna, an immigrant from the former Soviet Union, found success in America as CEO of Just Home Healthcare Services, growing it to a $60M company and achieving an 8X EBITDA exit. Her personal experience with addiction, including her children’s struggles, drives her role as an investor and advisor at Loosid App, supporting recovery and growth.
Nina Hendricks
COO of the Loosid Sober Community
Nina, with 15+ years in operations, is a key advocate for addiction recovery and a developer of Loosid’s SAM™ technology. She supports women in recovery while balancing her new roles as a mom and wife.
Our Team
Sen-Jam Pharmaceutical
Loosid Sober Community
Jim Iversen
Co-Founder, CEO
Serial entrepreneur and innovative disruptor. 5 exits at $80M. Scaled companies from 0-160 employees & to $50M revenue at W&H Systems, Mincron, and AL Systems. Seasoned CEO and global humanitarian. BS Mechanical Engineering.
MJ Gottlieb
Co-Founder, CEO
MJ Gottlieb, a serial entrepreneur and recovery advocate, has led multiple brands and agencies over 29 years. Featured in top publications and author of How To Ruin A Business Without Really Trying, he has been sober since 2012 and hosts Loosid’s Recovery Voices.
Jackie Iversen
Co-Founder, Head of Clinical Development
Pharmacist & clinical research expert in pharmacokinetics & pain management. Leading clinical pain educator. Cited in 20+ scientific publications including Pharmacy Times. Memorial Sloan Kettering Fellow. BS Pharmacy, MS Pharmacy, St. John’s University.
Zhanna Basina
Co-Founder & Senior Advisor of the Loosid Sober Community
Zhanna, an immigrant from the former Soviet Union,found success in America as CEO of Just Home Healthcare Services, growing it to a $60M company & achieving an 8X EBITDA exit. Her personal experience with addiction, including her children’s struggles, drives her role as an investor and advisor at Loosid App, supporting recovery and growth.
Thomas Dahl, PhD
Head of Product Development and Regulatory Affairs
Pharmaceutical clinical development and regulatory expert. Former biotech or pharmaceutical executive at Synta, ViuRX, Arietis, Greatbrook Biotech. Biochemistry & Biology PhD, John Hopkins University.
Nina Hendricks
COO of the Loosid Sober
Community
Nina, with 15+ years in operations, is a key advocate for addiction recovery and a developer of Loosid’s SAM™ technology. She supports women in recovery while balancing her new roles as a mom and wife.
Follow Us On Social Media
Sen-Jam Pharmaceutical
Loosid Sober Community
Follow Us On Social Media
Sen-Jam Pharmaceutical
Loosid Sober Community
© 2024 Sen-Jam Pharmaceutical
223 Wall Street #130
Huntington, NY 11743